192 related articles for article (PubMed ID: 16178761)
1. Novel therapies for asthma--advances and problems.
Walsh GM
Curr Pharm Des; 2005; 11(23):3027-38. PubMed ID: 16178761
[TBL] [Abstract][Full Text] [Related]
2. Targeting airway inflammation: novel therapies for the treatment of asthma.
Walsh GM
Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for asthma.
Walsh GM
Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
[TBL] [Abstract][Full Text] [Related]
4. Control of eosinophil toxicity in the lung.
Walsh GM; Al-Rabia M; Blaylock MG; Sexton DW; Duncan CJ; Lawrie A
Curr Drug Targets Inflamm Allergy; 2005 Aug; 4(4):481-6. PubMed ID: 16101525
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma.
Walsh GM; Sexton DW; Blaylock MG
J Endocrinol; 2003 Jul; 178(1):37-43. PubMed ID: 12844334
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cells in asthma: mechanisms and implications for therapy.
Hamid Q; Tulic' MK; Liu MC; Moqbel R
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S5-S12; discussion S12-7. PubMed ID: 12532083
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapeutic options for asthma.
Colice GL
Am J Manag Care; 2011 Apr; 17 Suppl 3():S82-9. PubMed ID: 21761958
[TBL] [Abstract][Full Text] [Related]
8. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
11. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
[TBL] [Abstract][Full Text] [Related]
12. New advances and potential therapies for the treatment of asthma.
Belvisi MG; Hele DJ; Birrell MA
BioDrugs; 2004; 18(4):211-23. PubMed ID: 15244499
[TBL] [Abstract][Full Text] [Related]
13. New therapies for asthma: is there any progress?
Barnes PJ
Trends Pharmacol Sci; 2010 Jul; 31(7):335-43. PubMed ID: 20554041
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging therapies for the management of chronic inflammation in asthma.
DeKorte CJ
Am J Health Syst Pharm; 2003 Oct; 60(19):1949-59; quiz 1960-1. PubMed ID: 14531240
[TBL] [Abstract][Full Text] [Related]
15. [Corticoid therapy and bronchial inflammation in asthma. The use of bronchial biopsy].
Jaffuel D; Mathieu M; Torado de la Fuente P; Michel FB; Godard P; Demoly P
Rev Mal Respir; 1998 Jun; 15(3):225-38. PubMed ID: 9677630
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, inflammatory mediators, and mediator antagonists in asthma.
Lazarus SC
J Clin Pharmacol; 1998 Jul; 38(7):577-82. PubMed ID: 9702841
[TBL] [Abstract][Full Text] [Related]
17. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No.
Wenzel SE
Am J Respir Crit Care Med; 1998 Dec; 158(6):1699-701. PubMed ID: 9847255
[No Abstract] [Full Text] [Related]
18. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
[No Abstract] [Full Text] [Related]
19. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N
Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
